OligoM-Cancer: A multidimensional information platform for deep phenotyping of heterogenous oligometastatic cancer.

ABSTRACT: Patients with oligometastatic cancer (OMC) exhibit better response to local therapeutic interventions and a more treatable tendency than those with polymetastatic cancers. However, studies on OMC are limited and lack effective integration for systematic comparison and personalized application, and the diagnosis and precise treatment of OMC remain controversial. The application of large language models in medicine remains challenging because of the requirement of high-quality medical data. Moreover, these models must be enhanced using precise domain-specific knowledge. Therefore, we developed the OligoM-Cancer platform (http://oligo.sysbio.org.cn), pioneering knowledge curation that depicts various aspects of oligometastases spectrum, including markers, diagnosis, prognosis, and therapy cho

SUBMITTER: Wu R 

PROVIDER: S-EPMC11385025 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature